Siemens Expanding Capabilities, Increasing Productivity at SNMMI 2015

Jun 04, 2015

· New Symbia Evo SPECT system enhances productivity through streamlined workflow

· New Biograph RT Pro edition provides comprehensive PET/CT solution to expand capabilities into radiation therapy

 

At the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 6-10 at the Baltimore Convention Center, Siemens Healthcare debuts new technologies designed to expand the capabilities and improve the productivity of molecular imaging. Symbia Evo,™1 Siemens’ new single-photon emission computed tomography (SPECT) system, boosts user productivity, providing facilities with more time to plan treatment schedules, personalize studies, serve additional patients, and improve workflow efficiency. Also at SNMMI 2015, Siemens unveils the Biograph™ RT Pro edition, which leverages the premium positron emission tomography (PET) and CT technologies of the Biograph mCT family of large-bore scanners for radiation therapy (RT) treatment planning to provide physicians with the right image for the right plan. Additionally, Siemens introduces advanced RT functionality2 on its syngo.via® for Molecular Imaging (MI) imaging software solution that, with the Biograph RT Pro edition, provides flexible post-processing options that can be tailored to the clinical and workflow needs of both nuclear medicine and radiation oncology departments.

 

Symbia Evo

Recognizing the precious element of time in patient care, the new Symbia Evo SPECT system – the most recent addition to Siemens’ all-new Symbia™ family of SPECT and SPECT/CT systems – possesses unique features to help users read with greater confidence, image a wide variety of patients, and potentially double an institution’s patient throughput.

 

Symbia Evo automates routine manual tasks due to Automated Quality Control and Automated Collimator Changer. Siemens’ IQ•SPECT ultra-fast cardiac imaging solution offers the potential for vastly improved scan times. Possessing advanced HD detector technology, Symbia Evo offers industry-leading3 collimator sensitivity and 24 percent3 higher reconstructed image resolution for high-quality images that enable a more confident diagnosis. The system’s detector flexibility supports stretcher and hospital bed imaging, and the patient bed supports patients up to 500 lbs (227 kg.). Furthermore, the system’s lowest bed position offers easy access to patients with limited mobility.

 

Biograph RT Pro edition

Modern radiotherapy now delivers higher doses to more targeted areas of the tumor, resulting in the need for greater precision in the planning process – and, in turn, an increased reliance on PET/CT imaging due to its ability to visualize both metabolic and anatomical information. Eighty-six percent of radiation therapy sites that use medical images in their treatment plans utilize PET images, with PET use in RT planning protocols increasing five-fold over the past decade.4 The new Biograph RT Pro edition of Siemens’ Biograph mCT family is a comprehensive solution tailored for RT treatment planning, enabling physicians to devise treatment strategies with confidence.

 

Biograph RT Pro edition allows nuclear medicine departments to expand their service lines to radiation oncology, in addition to providing a complete solution for dedicated RT professionals. This solution includes Siemens' HD FoV Pro2 algorithm, which uses intelligent contour and attenuation estimation to further improve visibility outside the scan field of view (FoV), enabling visualization of the body outline up to 78 cm for RTP planning and bariatric patients, in certain cases, while providing sufficient HU accuracy. Biograph RT Pro edition integrates metal artifact reduction into the PET/CT imaging workflow with iMAR2 (iterative metal artifact reduction), which is designed to yield images with a reduced level of metal artifact distortion caused by hip implants, shoulder prostheses, dental fillings, and other forms of implanted metal in the patient.

 

Biograph RT Pro edition offers a full suite of motion management technologies for precise therapy planning, with an integrated user interface between PET and CT that allows for time-, phase- and amplitude-based gating. The t-MIP2 feature helps visualize tumor movement in a single image. The phase-matched gating capability enables one-click matching of PET and CT gated datasets to correct for misregistration, improving image quality and quantification. The amplitude-based gating feature HD•Chest virtually freezes respiratory motion, providing full HD lesion detection without impacting current PET/CT patient scheduling. This suite of motion management tools allows the physician to account for motion management in treatment planning.

 

The advanced modeling of Siemens’ ADMIRE2 (Advanced Modeled Iterative Reconstruction) CT algorithm provides superb image detail, delineation, and sharpness of organ borders. Finally, the TwinBeam Dual Energy2 feature permits the simultaneous acquisition of data from high- and low-energy spectra, offering uncompromised image quality.

 

syngo.via for MI with advanced RT functionality

Designed to provide flexible solutions that bring together nuclear medicine and radiation oncology departments for optimized radiation therapy planning and improved patient outcomes, Siemens’ new syngo.via for MI software with advanced RT functionality enables more precise tumor contouring. It also provides greater flexibility to share clinical information with imaging and referring physicians to establish initial and subsequent treatment strategies. syngo.via for MI with advanced RT functionality includes a gross tumor volume contouring tool2 that allows nuclear medicine physicians and radiation oncologists to place and manually adjust tumor contours based on quantitative SUV measurements.

 

 

Contact for journalists

Jeff Bell
Siemens Healthcare
Phone: 610-448-1477; E-mail: jeffrey.t.bell@siemens.com
Follow us on Twitter: www.twitter.com/SiemensHealth

 

 

Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of combined cycle turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2014, which ended on September 30, 2014, Siemens generated revenue from continuing operations of €71.9 billion and net income of €5.5 billion. At the end of September 2014, the company had around 357,000 employees worldwide. Further information is available on the Internet at http://www.siemens.com.

 

1Symbia Evo is not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

2HD FoV Pro, iMAR, t-MIP, Twin Beam Dual Energy, ADMIRE and syngo.via for MI with advanced RT features are pending 510(k) clearance, and are not yet commercially available in the United States or in all countries worldwide. Due to regulatory reasons, their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

3Based on competitive literature available at time of publication. Data on file.

4U.S. IMV 2012-13 Radiation Therapy Market Summary Report